David Elsley

Cardiol Therapeutics Inc. (NASDAQ:CRDL), a clinical-stage life sciences company, reported results from its Phase II open-label MAvERIC-Pilot study of CardiolRx, a cannabidiol-based therapy for treating symptomatic recurrent pericarditis. Cannabidiol (CBD) is a non-psychoactive compound found in the...

The cannabis space has seen a few large-scale deals in the medical space, but this begs the question: why isn't big pharma much more involved in the industry? Megan Henderson, executive producer of The GrowthOp, moderated a panel of experts Wednesday at the Benzinga Capital Cannabis...

It's that time again. The Benzinga Events team is busy planning for the third Cannabis Capital Conference back in one of our favorite spots and the heart of the cannabis industry—Toronto. The cannabis industry is constantly developing, from market expansions and stock volatility to recent...